Anhui New Star Pharmaceutical Development Co.; Ltd
发明人:
Xianming Deng,Dawang Zhou,Lanfen Chen,Zhixiang He,Fuqin Fan
申请号：
US16077634
公开号：
US20200115386A1
申请日:
2017.03.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to compounds (I) capable of inhibiting the Mst1/2 protein kinase activity, a preparation method therefor, a pharmaceutical composition comprising the compounds, and uses of the compounds and the pharmaceutical composition comprising the compounds in the preparation of drugs for prompting repair and regeneration of tissues and organs, prompting stem cell proliferation and somatic cell dedifferentiation, immunosuppression, and preventing or treating diseases related to nervous disorders and local ischemia.
